Adhoc: Kuros Biosciences AG: Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024
Kuros Biosciences AG / Key word(s): Quarter Results Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024 10-Oct-2024 / 07:00 CET/CE…